Adenosine receptors as therapeutic targets - Wikidata - awgldk - TriplyDB

Adenosine receptors as therapeutic targets

Adenosine receptors as therapeutic targets

http://www.wikidata.org/entity/Q24632095

about

An emerging role for adenosine and its receptors in bone homeostasis Flexible modulation of agonist efficacy at the human A3 adenosine receptor by the imidazoquinoline allosteric enhancer LUF6000 Prostatic acid phosphatase is an ectonucleotidase and suppresses pain by generating adenosine Translocation of arrestin induced by human A(3) adenosine receptor ligands in an engineered cell line: comparison with G protein-dependent pathways Adenosine receptors: therapeutic aspects for inflammatory and immune diseases.A2A receptors in inflammation and injury: lessons learned from transgenic animals The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist Excess adenosine in murine penile erectile tissues contributes to priapism via A2B adenosine receptor signaling Purinergic signalling in neuron-glia interactions Progress and perspectives on targeting nanoparticles for brain drug delivery.Adenosine receptor signaling: a key to opening the blood-brain door Adenosine kinase: exploitation for therapeutic gain.Potential for developing purinergic drugs for gastrointestinal diseases The role of adenosine signaling in sickle cell therapeutics Hyperkalemic cardioplegia for adult and pediatric surgery: end of an era?Impaired adenosine-mediated angiogenesis in preeclampsia: potential implications for fetal programming Molecular recognition at the active site of catechol-O-methyltransferase (COMT): adenine replacements in bisubstrate inhibitors Structure of the Adenosine A2A Receptor in Complex with ZM241385 and the Xanthines XAC and Caffeine Recent developments in adenosine receptor ligands and their potential as novel drugs Guanosine: a Neuromodulator with Therapeutic Potential in Brain Disorders Adenosine A2B Receptor: From Cell Biology to Human Diseases Beneficial and detrimental role of adenosine signaling in diseases and therapy Emerging adenosine receptor agonists Hypoxia induces cardiac malformations via A1 adenosine receptor activation in chicken embryos Oral methylthioadenosine administration attenuates fibrosis and chronic liver disease progression in Mdr2-/- mice Genetic removal of the A2A adenosine receptor enhances pulmonary inflammation, mucin production, and angiogenesis in adenosine deaminase-deficient mice Anticonvulsant activity of B2, an adenosine analog, on chemical convulsant-induced seizures Adenosine receptors as drug targets--what are the challenges?Equilibrative nucleoside transporters-A review.NOX2 Activation of Natural Killer T Cells Is Blocked by the Adenosine A2A Receptor to Inhibit Lung Ischemia-Reperfusion Injury Adenosine 2A receptors in acute kidney injury Pharmacokinetic Properties of Adenosine Amine Congener in Cochlear Perilymph after Systemic Administration History of Chemistry in the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).Evaluation of homology modeling of G-protein-coupled receptors in light of the A(2A) adenosine receptor crystallographic structure.Adenosine Receptors: The Contributions by John W. Daly.Mechanisms of sensorineural cell damage, death and survival in the cochlea.Targeting of adenosine receptors in ischemia-reperfusion injury.Adenosine amine congener as a cochlear rescue agent.Structure-based discovery of novel chemotypes for adenosine A(2A) receptor antagonists.Identification of zebrafish A2 adenosine receptors and expression in developing embryos

P2860

Q21131280-DB1F5B29-11DB-4CC5-8F3E-2997417328B8 Q21262008-7D173C06-2862-494B-981E-392DEE1CFD18 Q24336492-25DB86C7-35FF-42EF-A3E8-38B3C55E91CB Q24646643-A033F809-0D45-45EF-9DD8-B914A5FD477C Q24651475-3ED8287F-22DE-4E80-A73F-517D92F9D4A3 Q24652486-2480845D-E6F5-4061-B788-B278E02F9D0A Q24654563-D776E007-BAFA-41B6-9E6B-D615F4B0ACB3 Q24655020-683D23C4-8537-4B17-B5E8-AB887A0317B0 Q24684324-F1E4E2E6-2390-4E76-B698-C0454E6B5735 Q26740580-4F7F1115-A5F8-4C95-8FC3-5C8C9F6C4CFC Q26795435-9C674DAC-BF11-42D5-B15A-25A455F17879 Q26852056-377A5C96-8843-4063-9BE4-02DB540EFF82 Q27000719-DEDAF19E-98D8-4D0E-B9F5-59927C66F2AC Q27010098-457E1C73-66EF-4714-B003-CAFF891F1B9A Q27022674-7709FF21-54E1-4104-B4FD-8A5B3F825D2F Q27024603-11BC95AC-98EF-4B16-A170-F0705062E915 Q27667660-C8874756-A8C6-4525-B7B9-AE077CE1B66B Q27672832-2D3BEBF0-582E-472C-9090-BDA5FE6C71D1 Q27687253-9DE57359-10D7-4ED1-836F-C5E8E4F69A5E Q28072158-67F0CD9B-A804-4CA1-9D5D-9001719E7D44 Q28074665-C06DD345-86A4-471F-9021-6E9C668B715D Q28080872-DB9B2BFE-8DE1-44A0-AC1A-B335C75098EB Q28249111-469BDD5C-733A-44A5-8525-FAC76D1A895A Q28264264-955191EE-F5AF-462B-B7BF-310C9D866924 Q28476642-04F6F2C8-DFC2-4432-A1B9-ABCEB3EA1D49 Q28512453-4ABDB464-71BB-4F1A-8906-E8574C994EFA Q28534300-07A23A36-0FC7-4B20-A4FC-D987D1034267 Q29346491-640BAFCC-DCEA-4979-8DF8-22764A7471EF Q30244329-05491878-56B7-48EC-A300-F8EB8EAFA5BE Q30277768-53B111B6-D931-4CE1-A93A-5F99BC163B0A Q30300186-4EC0192A-1C79-43F4-8232-8AB968FF8731 Q30363358-65A9FA49-5631-44EC-9A97-E290E406DDAD Q30370827-FBB5E749-5FB4-4E07-8D7F-03494388A43E Q30376612-A64BF6A2-C24C-4C99-B2FD-928902F2A107 Q30384658-FA0F0B5F-7D7E-47B9-ABA2-E0D73C9693E0 Q30412447-A7C85598-37D9-4251-9B1F-FE257A810BE8 Q30429069-A542F481-BE5E-4F44-B025-88849E0AC468 Q30430524-3E9EA0C3-443F-46FE-880F-18012089823B Q30435017-3A6737DA-0173-42B8-BDC0-4DA6D0BBA5E7 Q30436906-FF8C898B-991E-4BEC-BC45-7F730A47DE8F

P2860

Adenosine receptors as therapeutic targets

http://www.wikidata.org/entity/Q24632095

description

2006 nî lūn-bûn

@nan

2006 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի մարտին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Adenosine receptors as therapeutic targets

@ast

Adenosine receptors as therapeutic targets

@en

Adenosine receptors as therapeutic targets

@nl

type

label

Adenosine receptors as therapeutic targets

@ast

Adenosine receptors as therapeutic targets

@en

Adenosine receptors as therapeutic targets

@nl

prefLabel

Adenosine receptors as therapeutic targets

@ast

Adenosine receptors as therapeutic targets

@en

Adenosine receptors as therapeutic targets

@nl

P1433

Q24632095-D80F2BBA-EB8F-44CC-9C8E-D967553EDD65

P1476

Q24632095-32946CD0-2C99-4DB6-A13F-37237A52BE16

P2093

Q24632095-2AE35BFC-79AA-4C93-8F5C-EC985EA64C32

Q24632095-DCF260DC-E2E6-4FFD-9F2F-F2D45D0A5971

P2860

Q24632095-00E53B45-E7CA-4903-83F4-12F6E1F8CFD1

Q24632095-04748A75-8209-4501-A7C9-3D1690985648

Q24632095-05BAEFA3-EB69-4DC6-8A8F-4BE978621D37

Q24632095-09711722-E769-4F67-890B-864E4E4890E7

Q24632095-0AB421C6-75F8-40A8-B3EC-4261E9832BA4

Q24632095-0B1B0427-C6A0-4F9E-B18A-D2188B4C66A7

Q24632095-10A7C410-C424-45D8-BE7F-897AF4FA0251

Q24632095-111026EA-9797-47F8-B1E6-5C7458DD125B

Q24632095-113B2184-959C-4B84-B7CD-BCD1E595F1B8

Q24632095-115D45F2-FAE4-4C46-A0E4-C663395F7DC5

P2888

Q24632095-D42BEC62-FC15-4FB0-A147-C6DFE215FA48

P304

Q24632095-6AFEA838-4A3E-4181-83A0-D817F9312212

P31

Q24632095-210A730F-FB2E-4AC7-9218-672A4C312ADF

P3181

Q24632095-80120621-70D6-49B2-AFFE-3AF8722086B3

P356

Q24632095-BE51D596-90E9-4825-8495-E1931759FD88

P407

Q24632095-C130960D-008E-4D0F-B82B-9131AD00F102

P433

Q24632095-1424D7D7-6ED1-4ED3-91FD-8423D5417B61

P478

Q24632095-ADE9D421-B476-4684-85E4-3AE8E24E0B69

P577

Q24632095-31B8F454-BDFB-4950-9052-74116656325E

P5875

Q24632095-67EF4AA8-3054-4246-AD02-B08B4A829879

P6179

Q24632095-46F38E6A-F2EB-40A3-B62C-0CB9F2DF26CB

P698

Q24632095-44B4152D-F468-41FE-9895-CE6BC1A3ECBD

P932

Q24632095-5073278C-168C-4E32-AA36-CFD4B1050A33

P3181

P356

P1433

Nature Reviews Drug Discovery

P1476

Adenosine receptors as therapeutic targets

@en

P2093

Kenneth A Jacobson

http://www.w3.org/2001/XMLSchema#string

Zhan-Guo Gao

http://www.w3.org/2001/XMLSchema#string

P2860

Dose and time effects of caffeine intake on human platelet adenosine A(2A) receptors : functional and biochemical aspects

Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor

G alpha 15 and G alpha 16 couple a wide variety of receptors to phospholipase C

Stimulation of high-affinity adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes

125I-4-(2-[7-amino-2-[2-furyl][1,2,4]triazolo[2,3-a][1,3,5] triazin-5-yl-amino]ethyl)phenol, a high affinity antagonist radioligand selective for the A2a adenosine receptor

Coordinated adenine nucleotide phosphohydrolysis and nucleoside signaling in posthypoxic endothelium: role of ectonucleotidases and adenosine A2B receptors

Progress in pursuit of therapeutic A2A antagonists: the adenosine A2A receptor selective antagonist KW6002: research and development toward a novel nondopaminergic therapy for Parkinson's disease

Discovery of nonxanthine adenosine A2A receptor antagonists for the treatment of Parkinson's disease

Coaggregation, cointernalization, and codesensitization of adenosine A2A receptors and dopamine D2 receptors

Medicinal chemistry and pharmacology of A2B adenosine receptors

P2888

P304

247-64

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1323826

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/NRD1983

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2006-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7260478

http://www.w3.org/2001/XMLSchema#string

P6179

1044863123

http://www.w3.org/2001/XMLSchema#string

P698

16518376

http://www.w3.org/2001/XMLSchema#string

P932

3463109

http://www.w3.org/2001/XMLSchema#string